Astrazeneca (AZN) Net Income Growth (5y) (2014 - 2026)
Analysis
Astrazeneca (AZN) Net Income Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.78 Bn | 602.80 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 362.62 Bn | 362.62 Bn | - |
| 3 | General Electric | 329.79 Bn | 320.45 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.78 Bn | 248.49 Bn | 12.86 Bn |
| 5 | Citigroup | 228.38 Bn | -2,073.93 Bn | 24.75 Bn |
| 6 | Bhp | 216.07 Bn | 197.52 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - |
| 9 | Unilever | 139.31 Bn | 132.28 Bn | - |
| 10 | Hdfc Bank | 117.84 Bn | 80.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.87% |
| Mar 31, 2026 | 23.47% |
| Dec 31, 2025 | 60.38% |
| Sep 30, 2025 | 30.24% |
| Jun 30, 2025 | 26.31% |
| Mar 31, 2025 | 28.23% |
| Dec 31, 2024 | 55.27% |
| Sep 30, 2024 | 32.81% |
| Jun 30, 2024 | 93.01% |
| Mar 31, 2024 | 29.12% |
| Dec 31, 2023 | 73.06% |
| Sep 30, 2023 | 28.58% |
| Jun 30, 2023 | 49.17% |
| Mar 31, 2023 | 44.48% |
| Dec 31, 2022 | 28.20% |
| Sep 30, 2022 | -24.85% |
| Jun 30, 2022 | -21.38% |
| Mar 31, 2022 | 1.95% |
| Dec 31, 2021 | -18.77% |
| Sep 30, 2021 | -53.73% |